Inactivated Vaccines Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
A biological preparation that enhances acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body's immune system is stimulated by the agent, which is recognized as a foreign body by this immune system. The agent is then destroyed and remembered by the immune system. The vaccine agents are inactivated or killed in different ways to reduce infectivity in order to avoid vaccine infections.
MARKET DYNAMICS
The inactivated vaccines market is driving due to the rising demand for inactivated vaccines from governments of industrialized and developing countries. However, stringent government regulations regarding efficacy and safety and lack of supply of vaccines in remote areas is likely to restraint the market growth during the forecast period. Moreover, prevalence of infectious diseases and rise in awareness among people about immunization are other factors propelling the market.
MARKET SCOPE
The "Inactivated Vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of inactivated vaccines market with detailed market segmentation by type, method and route of administration. The inactivated vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in inactivated vaccines market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The inactivated vaccines market is segmented on the basis of type, method and route of administration. Based on type, the market is segmented as viral vaccine and bacterial vaccine. On the basis of method, the market is categorized as solvent detergent method, radiation method, pH concentration, heat inactivation and others. On the basis of route of administration, the market is categorized as oral, subcutaneous, intravenous and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the inactivated vaccines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inactivated vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting inactivated vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inactivated vaccines market in these regions.
By Type
By Method
By Route of Administration
MARKET PLAYERS
The report covers key developments in the inactivated vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inactivated vaccines market are anticipated to have lucrative growth opportunities in the future with the rising demand for inactivated vaccines in the global market. Below mentioned is the list of few companies engaged in the inactivated vaccines market.
The report also includes the profiles of key players in inactivated vaccines market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
A biological preparation that enhances acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body's immune system is stimulated by the agent, which is recognized as a foreign body by this immune system. The agent is then destroyed and remembered by the immune system. The vaccine agents are inactivated or killed in different ways to reduce infectivity in order to avoid vaccine infections.
MARKET DYNAMICS
The inactivated vaccines market is driving due to the rising demand for inactivated vaccines from governments of industrialized and developing countries. However, stringent government regulations regarding efficacy and safety and lack of supply of vaccines in remote areas is likely to restraint the market growth during the forecast period. Moreover, prevalence of infectious diseases and rise in awareness among people about immunization are other factors propelling the market.
MARKET SCOPE
The "Inactivated Vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of inactivated vaccines market with detailed market segmentation by type, method and route of administration. The inactivated vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in inactivated vaccines market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The inactivated vaccines market is segmented on the basis of type, method and route of administration. Based on type, the market is segmented as viral vaccine and bacterial vaccine. On the basis of method, the market is categorized as solvent detergent method, radiation method, pH concentration, heat inactivation and others. On the basis of route of administration, the market is categorized as oral, subcutaneous, intravenous and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the inactivated vaccines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inactivated vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting inactivated vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inactivated vaccines market in these regions.
Inactivated Vaccines Market Report Analysis
Inactivated Vaccines Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Bharat Biotech
- CSL Ltd.
- Emergent BioSolutions
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Seqirus
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- Viral Vaccine
- Bacterial Vaccine
By Method
- Solvent Detergent Method
- Radiation Method
- pH Concentration
- Heat Inactivation
- Others
By Route of Administration
- Oral
- Subcutaneous
- Intravenous
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the inactivated vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inactivated vaccines market are anticipated to have lucrative growth opportunities in the future with the rising demand for inactivated vaccines in the global market. Below mentioned is the list of few companies engaged in the inactivated vaccines market.
The report also includes the profiles of key players in inactivated vaccines market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bharat Biotech
- CSL Ltd.
- Emergent BioSolutions
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Seqirus
- Valneva SE
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Inactivated Vaccines Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Bharat Biotech
2. CSL Ltd.
3. Emergent BioSolutions
4. GlaxoSmithKline plc
5. Merck & Co., Inc.
6. Novartis AG
7. Pfizer Inc.
8. Sanofi
9. Seqirus
10. Valneva SE
1. Bharat Biotech
2. CSL Ltd.
3. Emergent BioSolutions
4. GlaxoSmithKline plc
5. Merck & Co., Inc.
6. Novartis AG
7. Pfizer Inc.
8. Sanofi
9. Seqirus
10. Valneva SE
Get Free Sample For